T4	Effect 31 52	cutaneous scleroderma
T5	Subject 56 66	3 patients
T6	Treatment 83 146	the use of bleomycin in low cumulative doses of less than 100 U
T7	Population 56 57	3
T8	Drug 94 103	bleomycin
T9	Dosage 131 146	less than 100 U
T3	Adverse_event 16 27	development
E1	Adverse_event:T3